Total Bullshit & Broken Business Model

Schiller testified Valeant did not raise the price of Xifaxin after acquisition when asked by Senator McCaskill to name 1 drug Valeant did not raise price. Total bullshit, it's been raised at least twice.

Ackman pressed to provide real proof Valeant will adhere to an ethical business model. Take my word for it he says. Then was pressed and agreed to within weeks have a company code of ethics published and business rules against agregious price increases.

Valeant business model is officially dead... assets will have to be sold to pay debt.

 

SELL B&L!!!!

 

as if the remnants of B&L are attractive or can survive
alone...

 

Yes, Xifaxan price went from around $1200.00/month to around $1800.00/month shorty after the Salix acquistion. We sold Xifaxan and were all aware of the price increase. We complained about it to each other last summer.